Lymphoma; clinical trials; immunotherapy; cellular therapy; CAR-T
BS: Massachusetts Institute of Technology, 2007; MD: Case Western Reserve University, 2011; Internal Medicine Resident: University of Virginia, 2011-2014; Hematology/Oncology Fellow: University of North Carolina, 2014-2017; Assistant Professor of Medicine: University of North Carolina, 2017-present.
Research and Clinical Interests
Dr. Grover’s primary clinical interest is management of lymphoma. Her research interests include novel treatment strategies in lymphoma, particularly immunotherapy, and she is currently involved in the clinical trials of chimeric antigen receptor T-cell (CAR-T) therapy for patients with lymphoma. She is interested in innovative approaches to CAR-T therapy, improving the efficacy of CAR-T cells, and management and prevention of the unique toxicities associated with this therapy. Her ultimate goal is to improve therapeutic options for lymphoma patients, while minimizing toxicities and maintaining their quality of life.